Industry Insights

导航菜单

ZMUni Joins UK–China Roundtable at PCHi 2026, Exploring Collaboration in the Personal Care Industry

Global Cosmetic Regulatory Updates in March 2026

China Proposes Optimized Policies for Cosmetics Registration & Notification: First Launches, Animal Testing Exemption...

ZMUni Seminar Recap: Practical Insights on Global Cosmetic Compliance During PCHi 2026 Week

Leveraging China's Local Policy Incentives: How Imported Cosmetics Can Benefit

Recommended Reading

Leveraging China's Local Policy Incentives: How Imported Cosmetics Can Benefit

What Cosmetics Brands Need to Know About Selling Online in China, the EU, the US, and ASEAN

Entering China's Cosmetic Market: Understanding the Responsible Person Role

News Subscription

Business Cooperation

Industry Insights 资讯/缺省

2'-Fucosyllactose Firstly Filed as New Cosmetic Ingredient in China

In January 2024 (as of January 17th), the National Medical Products Administration of China announced the filing of 8 new cosmetic ingredients. One of them is Fucosyllactose (No. 20240006), and the company filing it is Bloomage Biotech. *Info of No. 20240006 new cosmetic ingredient released by China NMPA Before this, Bloomage Biotech had already filed 4 other new cosmetic ingredients, namely Zinc Hyaluronate Hydrolysate, N-Acetylneuraminic Acid, Hydrolyzed Calcium Hyaluronate, and Aminolevulinic Acid HCl. About Fucosyllactose: Fucosyllactose, also known as 2'-Fucosyllactose (2'-FL), is a disaccharide compound composed of fucosyl and lactose. Fucosyl is a polysaccharide naturally found in seaweed, fungi,